Good Clinical Practice (GCP) Compliance

GCP Responsibilities in Decentralized and Telemedicine-Enabled Trials

Posted on By digi

GCP Responsibilities in Decentralized and Telemedicine-Enabled Trials GCP Responsibilities in Decentralized and Telemedicine-Enabled Trials The landscape of clinical trials is rapidly changing, driven by advances in technology and changing patient expectations. Decentralized clinical trials (DCTs) and telemedicine-enabled trials represent a fundamental shift in the way clinical research is conducted. This tutorial provides an in-depth look…

Read More “GCP Responsibilities in Decentralized and Telemedicine-Enabled Trials” »

Investigator Responsibilities under GCP

Strategies for PIs to Demonstrate Continuous GCP Compliance During Inspections

Posted on By digi

Strategies for PIs to Demonstrate Continuous GCP Compliance During Inspections Strategies for PIs to Demonstrate Continuous GCP Compliance During Inspections Ensuring compliance with Good Clinical Practice (GCP) is essential for Principal Investigators (PIs) overseeing clinical trials. This is especially crucial during inspections by regulatory authorities such as the FDA, EMA, and MHRA. In this tutorial,…

Read More “Strategies for PIs to Demonstrate Continuous GCP Compliance During Inspections” »

Investigator Responsibilities under GCP

PI Oversight When Using External Vendors, Labs and Home Health Providers

Posted on By digi

PI Oversight When Using External Vendors, Labs and Home Health Providers In the landscape of clinical research, Principal Investigators (PIs) are tasked with numerous responsibilities that extend beyond their immediate research teams. As clinical trials increasingly engage external vendors, laboratories, and home health service providers, understanding the PI’s oversight responsibilities becomes essential. This article provides…

Read More “PI Oversight When Using External Vendors, Labs and Home Health Providers” »

Investigator Responsibilities under GCP

CRO Responsibilities Under GCP: Where Outsourcing Ends and Accountability Remains

Posted on By digi

CRO Responsibilities Under GCP: Where Outsourcing Ends and Accountability Remains CRO Responsibilities Under GCP: Where Outsourcing Ends and Accountability Remains In the realm of clinical trials, the outsourcing of responsibilities to Contract Research Organizations (CROs) has become a prevalent practice amongst sponsors. Nevertheless, while outsourcing is commonplace, it is imperative that sponsors understand the regulatory…

Read More “CRO Responsibilities Under GCP: Where Outsourcing Ends and Accountability Remains” »

Sponsor & CRO GCP Obligations

Sponsor GCP Obligations: Oversight, Quality Management and Risk Control

Posted on By digi

Sponsor GCP Obligations: Oversight, Quality Management and Risk Control Sponsor GCP Obligations: Oversight, Quality Management and Risk Control Clinical trials are a fundamental part of the drug development process, providing the necessary evidence for regulatory approvals and subsequent market access. The obligations of sponsors under Good Clinical Practice (GCP) ensure the ethical and scientific integrity…

Read More “Sponsor GCP Obligations: Oversight, Quality Management and Risk Control” »

Sponsor & CRO GCP Obligations

Vendor Qualification, Selection and Management as a GCP Requirement

Posted on By digi

Vendor Qualification, Selection and Management as a GCP Requirement Vendor Qualification, Selection and Management as a GCP Requirement In the context of clinical trials, ensuring that vendors adhere to Good Clinical Practice (GCP) standards is imperative for maintaining compliance and achieving success in research outcomes. This article presents a comprehensive step-by-step guide to effective vendor…

Read More “Vendor Qualification, Selection and Management as a GCP Requirement” »

Sponsor & CRO GCP Obligations

Designing a Sponsor Oversight Model That Meets ICH E6(R3) Expectations

Posted on By digi

Designing a Sponsor Oversight Model That Meets ICH E6(R3) Expectations Designing a Sponsor Oversight Model That Meets ICH E6(R3) Expectations In the evolving landscape of clinical research, effective oversight by sponsors is essential for ensuring compliance with regulatory guidelines and the successful completion of clinical trials. The ICH E6(R3) guidelines introduce specific expectations for sponsor…

Read More “Designing a Sponsor Oversight Model That Meets ICH E6(R3) Expectations” »

Sponsor & CRO GCP Obligations

GCP Obligations for Safety Management, Pharmacovigilance and Signal Detection

Posted on By digi

GCP Obligations for Safety Management, Pharmacovigilance and Signal Detection GCP Obligations for Safety Management, Pharmacovigilance and Signal Detection Understanding GCP Obligations in Clinical Trials Good Clinical Practice (GCP) serves as an essential foundation for conducting clinical trials across various regions, including the US, UK, and the EU. The obligations outlined by GCP ensure the protection…

Read More “GCP Obligations for Safety Management, Pharmacovigilance and Signal Detection” »

Sponsor & CRO GCP Obligations

Risk-Based Quality Management Systems for Sponsors and CROs

Posted on By digi

Risk-Based Quality Management Systems for Sponsors and CROs In the realm of clinical trials, particularly in contexts such as non-small cell lung cancer clinical trials, the implementation of a Risk-Based Quality Management System (RBQM) is essential for ensuring compliance and enhancing the quality of research. This guide provides a comprehensive overview of RBQM systems for…

Read More “Risk-Based Quality Management Systems for Sponsors and CROs” »

Sponsor & CRO GCP Obligations

Sponsor Responsibilities in Decentralized and Platform Trial Models

Posted on By digi

Sponsor Responsibilities in Decentralized and Platform Trial Models Sponsor Responsibilities in Decentralized and Platform Trial Models Introduction to Decentralized and Platform Trials In the evolving landscape of clinical research, decentralized and platform trial models have gained prominence, offering opportunities to enhance patient engagement, improve efficiency, and broaden the scope of data collection. These novel methodologies…

Read More “Sponsor Responsibilities in Decentralized and Platform Trial Models” »

Sponsor & CRO GCP Obligations